News

In industry parlance, Cargo had become a “zombie,” an unprofitable company with little hope for growth, but enough money to ...
On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...
CARGO Therapeutics to be acquired by Concentra Biosciences with shareholders receiving $4.379 per share and future asset sale ...
Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.
Merck has reached an agreement to acquire British pharmaceutical company Verona Pharma in a deal worth around $10 billion, ...
Family offices made 60 direct investments in companies, ending three straight months of declining deal activity.
The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June ...
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...
Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.
Former Senior Trump Health Official Urges Focus on Innovative "Upstream" Approaches that Disrupt Current Paradigm of Costly Chronic Care ...
According to new data, the global plant biotechnology market is projected to grow from $51.7 billion in 2025 to nearly $77 ...
An entrepreneur who founded one of the UK’s leading biotechnology companies has secured backing for a new venture that aims ...